Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login

Complex Diabetic Cases: A Closer Look at Clinical Trials

By: Allen C. Ho, MD, FACS; Jennifer I. Lim, MD

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 0.75

This case discussion between Allen C. Ho, MD, FACS, and Jennifer I. Lim, MD, focuses on more challenging cases of diabetic eye disease. Drs. Ho and Lim discuss the impact of pivotal trials and their applicability to patients in the real-world, which can be unpredictable and include barriers to care.

Expiration Date: Wednesday, August 31, 2022
Release Date: August 11, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the benefits of consistent anti-VEGF treatment.
  • Execute patient education plans on the importance of frequent DME treatment to improve treatment and exam compliance.
  • Apply best practices and strategies in a cross-disciplinary approach to diabetes management to better manage patients.

Accreditation and Designation Statement

This educational activity is provided by Evolve Medical Education LLC (Evolve).

Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Allen C. Ho, MD, FACS

Wills Eye Hospital
Attending Surgeon 
Director of Retina Research
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
President, The Retina Society

Jennifer I. Lim, MD

Marion H. Schenk Chair in Ophthalmology
Professor of Ophthalmology
Vice-Chair for Diversity & Inclusion
Director of the Retina Service
University of Illinois at Chicago
Chicago, IL

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Allen C. Ho, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Beaver-Visitec International, Chengdu Kanghong Biotechnology, Genentech, Regenxbio, Meira GTX Gyroscope, Clearside, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Notal Vision, Ocular Therapeutixs, ONL, Regeneron Pharmaceuticals. Grant/Research Support: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Chengdu Kanghong Biotechnolog, Genentech, Graybug, Gyroscope, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Lumithera, Meira G TX , National Eye Institute, Notal Vision, Novartis, ProQR, Regeneron Pharmaceuticals, Inc., and Regenxbio. Other support: Covalent.

Jennifer I. Lim, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisor: Alcon, Aura, Cognition, Eyenuk, Genentech, Novartis, Opthea, Quark, and Santen. Consultant: Luxa, and Unity. Grant/Research Support: Aldeyra, Chengdu Kanghong, Clearside, Genentech, NGM, Regeneron Pharmaceuticals, and Stealth. Patents/Royalty: CRC Press/Taylor and Francis.

The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals.

Begin Course